Clinical Trial Update: A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome [Phase 2]

View source ↗

Summary

This release summarizes results from a Phase 2 open-label study of aripiprazole in Fragile X Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-04-18